Loading...
84 companies we cover, 78 of them graded
Every company here put through the same five checks on growth and cash generation. It describes the industry as it reports today — not which of these to buy.
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LIMITED | A | $45.7B | $39.19 | 65.32 | $17.3B | 4.1% |
| HLN | Haleon plc | B+ | $41.4B | $9.26 | 18.87 | $14.6B | 15.1% |
| TAK | Takeda Pharmaceutical Company Limited | B | $30.3B | $18.86 | 44.01 | $28.7B | -3.4% |
| ZTS | Zoetis Inc. | A+ | $29.4B | $71.05 | 11.71 | $9.5B | 27.5% |
| VTRS | VIATRIS INC. | C | $20.5B | $17.83 | — | $14.7B | -23.9% |
| UTHR | United Therapeutics Corporation | B+ | $20.4B | $475.45 | 17.02 | $3.2B | 41.6% |
| NBIX | NEUROCRINE BIOSCIENCES INC | A+ | $14.1B | $138.40 | 20.29 | $3.4B | 20.9% |
| ELAN | Elanco Animal Health Incorporated | A | $11.1B | $22.31 | — | $5B | -4.0% |
| RDY | DR. REDDY’S LABORATORIES LIMITED | B+ | $10.2B | $12.25 | 17.35 | $3.5B | 12.8% |
| ALKS | Alkermes plc. | B | $6.9B | $40.85 | 107.50 | $1.7B | 4.0% |
| HIMS | HIMS & HERS HEALTH, INC. | A- | $6.8B | $29.42 | — | $2.6B | -5.5% |
| LNTH | Lantheus Holdings, Inc. | A+ | $6.5B | $99.74 | 24.15 | $1.6B | 17.7% |
| AMRX | AMNEAL PHARMACEUTICALS, INC. | C | $6.3B | $19.77 | 40.35 | $3.1B | 5.0% |
| KNSA | Kiniksa Pharmaceuticals International, plc | A | $6.2B | $75.08 | 82.51 | $754M | 9.7% |
| LQDA | LIQUIDIA CORPORATION | A+ | $6.1B | $68.43 | 49.23 | $450.9M | 30.7% |
| INDV | Indivior Pharmaceuticals, Inc. | D | $4.2B | $35.82 | 12.84 | $1.3B | 26.7% |
| AMLX | Amylyx Pharmaceuticals, Inc. | D | $3.3B | $29.49 | — | $0.00 | — |
| RGC | Regencell Bioscience Holdings Limited | not rated | $3.1B | $6.17 | — | — | — |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | C- | $2.5B | $42.66 | — | $830.4M | -13.2% |
| HCM | HutchMED (China) LIMITED | D | $2.4B | $13.94 | 26.81 | $549.1M | 3.3% |
| TRLV | TRULIEVE CANNABIS CORP. | D | $2.4B | $12.21 | — | $1.1B | -41.8% |
| PBH | PRESTIGE CONSUMER HEALTHCARE INC. | C+ | $2.2B | $46.61 | 13.06 | $1.1B | 15.6% |
| BCRX | BIOCRYST PHARMACEUTICALS, INC. | A | $2.2B | $8.59 | — | $940.6M | -40.9% |
| PRGO | Perrigo Company plc | F- | $2.1B | $15.42 | — | $4.1B | -41.9% |
| BHC | Bausch Health Companies Inc. | A | $2.1B | $5.69 | — | $10.9B | -10.1% |
| ALVO | ALVOTECH | B | $1.8B | $5.75 | 57.50 | $586.3M | 4.8% |
| XERS | XERIS BIOPHARMA HOLDINGS, INC. | F- | $1.7B | $9.10 | — | $335.4M | -5.1% |
| ETON | Eton Pharmaceuticals, Inc. | A+ | $1.6B | $57.68 | — | $105.6M | 12.0% |
| ANIP | ANI PHARMACEUTICALS, INC | A+ | $1.6B | $74.00 | 15.98 | $978.4M | 11.1% |
| PAHC | Phibro Animal Health Corporation | B | $1.4B | $34.45 | 14.12 | $1.5B | 6.6% |
| HROW | Harrow, Inc. | B- | $1.2B | $33.07 | — | $275.6M | -13.5% |
| CRON | CRONOS GROUP INC. | A | $1.2B | $3.34 | 16.70 | $179.1M | 39.1% |
| AMPH | Amphastar Pharmaceuticals, Inc. | A+ | $1.1B | $26.13 | 15.46 | $730M | 10.8% |
| PCRX | PACIRA BIOSCIENCES, INC. | A | $1B | $25.12 | 71.77 | $746.2M | 2.0% |
| COLL | Collegium Pharmaceutical, Inc. | A+ | $733.5M | $22.53 | 18.17 | $808.2M | 5.9% |
| IRWD | IRONWOOD PHARMACEUTICALS, INC. | C+ | $682.4M | $4.13 | 5.36 | $389.3M | 33.4% |
| AQST | Aquestive Therapeutics, Inc. | C | $587.4M | $4.68 | — | $54.1M | -144.6% |
| TLRY | Tilray Brands, Inc. | C- | $562.5M | $4.13 | — | $915.5M | -13.3% |
| GLAS | Glass House Brands Inc. | D- | $557.2M | $6.80 | — | $152.9M | -33.7% |
| EOLS | EVOLUS, INC. | B | $526.4M | $7.97 | — | $316.5M | -10.8% |
| KMDA | KAMADA LTD | C | $503M | $8.72 | 22.95 | $191.8M | 11.6% |
| TKNO | ALPHA TEKNOVA, INC. | B- | $500.9M | $9.33 | — | $43.7M | -38.4% |
| CGC | Canopy Growth Corp | D- | $398.3M | $0.94 | — | $207.3M | -79.2% |
| EBS | EMERGENT BIOSOLUTIONS INC. | C | $348.1M | $6.79 | — | $770.2M | -23.0% |
| BIOA | BIOAGE LABS, INC. | D- | $323.6M | $7.05 | — | $10.4M | -912.3% |
| INCR | INTERCURE LTD. | C- | $284.9M | $5.21 | — | $88.2M | -13.2% |
| EVO | Evotec SE | D- | $277.3M | $1.56 | — | $897M | -13.1% |
| ANIK | Anika Therapeutics, Inc. | B- | $272.6M | $20.37 | — | $120.7M | -3.1% |
| AKBA | AKEBIA THERAPEUTICS, INC. | C | $248.3M | $0.90 | — | $219.1M | -13.5% |
| SIGA | Siga Technologies INC | F- | $247.9M | $3.45 | — | $53.7M | -5.2% |
| ACB | AURORA CANNABIS INC | D | $230.6M | $4.10 | 145.20 | $226.3M | -42.4% |
| ORGO | ORGANOGENESIS HOLDINGS INC. | B- | $181.4M | $1.41 | — | $457.5M | -18.4% |
| CRDL | Cardiol Therapeutics Inc. | not rated | $171.4M | $1.71 | — | — | — |
| DERM | Journey Medical Corp | C- | $168.2M | $6.14 | — | $68.2M | -9.0% |
| ADCT | ADC Therapeutics SA | D | $162.1M | $1.27 | — | $79.6M | -121.8% |
| LFCR | LIFECORE BIOMEDICAL, INC. | D | $159M | $4.20 | — | $128.9M | -30.0% |
| CPIX | Cumberland Pharmaceuticals Inc. | F- | $114M | $7.61 | — | $39.9M | -27.4% |
| OGI | ORGANIGRAM HOLDINGS INC. | C- | $104.8M | $1.10 | — | $183M | -9.6% |
| CTOR | Citius Oncology, Inc. | not rated | $97.6M | $1.05 | — | — | — |
| ZYBT | Zhengye Biotechnology Holding Limited | D | $61.8M | $1.31 | 35.03 | $17.3M | -60.0% |
| SCYX | SCYNEXIS, Inc. | F- | $43.7M | $4.39 | 15.14 | $19.2M | -53.3% |
| IMCC | IM Cannabis Corp. | C | $36.4M | $2.84 | — | $32.3M | -39.1% |
| RMTI | ROCKWELL MEDICAL, INC. | B- | $33.7M | $8.37 | — | $69.4M | -7.3% |
| CPHI | CHINA PHARMA HOLDINGS, INC. | C- | $32.3M | $0.75 | — | $3.9M | -114.3% |
| BGM | BGM Group Ltd | F- | $27.2M | $0.24 | — | $37.9M | -52.6% |
| AYTU | AYTU BIOPHARMA, INC | C | $24.8M | $2.28 | — | $57.6M | -24.8% |
| TXMD | TherapeuticsMD, Inc. | F- | $23.7M | $2.05 | — | $3.3M | -6.6% |
| RDHL | REDHILL BIOPHARMA LTD. | F- | $22.5M | $0.50 | — | $286K | -150.0% |
| BFRI | Biofrontera Inc. | B- | $17.5M | $1.18 | — | $46.2M | -13.8% |
| TLPH | TALPHERA, INC. | C- | $16.8M | $1.18 | — | $1K | -1,507,600.0% |
| CABR | CARING BRANDS, INC. | F- | $12.8M | $1.24 | — | $4.2K | -183,255.2% |
| APUS | APIMEDS PHARMACEUTICALS US, INC. | not rated | $10.9M | $7.25 | — | — | — |
| INM | INMED PHARMACEUTICALS INC. | D- | $7.6M | $1.38 | — | $4.5M | -278.7% |
| SNOA | SONOMA PHARMACEUTICALS, INC. | B- | $6.1M | $1.27 | — | $21.9M | -10.3% |
| GELS | Gelteq Limited | D- | $5.2M | $0.55 | — | $116.3K | -4,011.9% |
| SBFM | Sunshine Biopharma Inc. | C- | $3.3M | $0.84 | — | $35.3M | -16.5% |
| SHPH | SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | not rated | $3M | $4.01 | — | — | — |
| UPC | Universe Pharmaceuticals INC | D- | $2.7M | $4.75 | — | $17.9B | -20.6% |
| SXTC | China SXT Pharmaceuticals, Inc. | F- | $2.5M | $2.57 | — | $1.1M | -545.2% |
| YCBD | cbdMD, Inc. | D- | $1.9M | $0.47 | — | $20.9M | -13.8% |
| IXHL | Incannex Healthcare Inc. | F- | $1.7M | $3.32 | — | $0.00 | — |
| PRFX | PRF Technologies Ltd. | B- | $811.3K | $0.98 | — | $17K | -29,541.2% |
| AKAN | AKANDA CORP. | F | $210.3K | $3.05 | 0.24 | $258.1K | -17,690.2% |
| OPTH | Optimi Health Corp. | not rated | — | $4.82 | — | — | — |
Fundamentals from SEC filings, prices from the last market-data pass. Sort by any column; companies with no figure sort last either way.
Sorted by market cap, largest first; click any column to re-sort. Companies with no figure sort last either way, because a missing P/E means unprofitable rather than cheap. Nothing here is a recommendation.